The pharmaceutical world is seeing a significant shift in glucose therapy with the introduction of GLP-1 transdermal devices. These patches offer a seemingly more user-friendly alternative to subcutaneous administrations of GLP-1 medications, reducing the frequency of daily needle sticks. The inn